Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
about
MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingTiny giants of gene regulation: experimental strategies for microRNA functional studiesHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionMicroRNA expression in hepatitis C virus-related malignancies: A brief reviewMicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesmiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsCurrent status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinomaMicroRNAs as potential target in human bone and soft tissue sarcoma therapeuticsThe Regulatory Role of MicroRNAs in EMT and CancerAnti-miRs competitively inhibit microRNAs in Argonaute complexesMicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) ReplicationFrom the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.Short loop-targeting oligoribonucleotides antagonize Lin28 and enable pre-let-7 processing and suppression of cell growth in let-7-deficient cancer cells.Nonconventional chemical inhibitors of microRNA: therapeutic scope.A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications.Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.MicroRNA as tools and therapeutics in lung cancerSite-specific conjugation of drug-like fragments to an antimiR scaffold as a strategy to target miRNAs inside RISC.HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge.A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis.Epigenetic-based immune intervention for rheumatic diseases.Antiviral therapy for chronic hepatitis C in 2014.MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?New treatments for chronic hepatitis C: an overview for paediatricians.Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance.Therapeutic oligonucleotides with polyethylene glycol modifications.Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.Innate Immunity Post-Hematopoietic Stem Cell Transplantation: Focus on EpigeneticsEnvironmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.Missing link between microRNA and prostate cancer.Exploiting microRNAs As Cancer Therapeutics.MicroRNAs in metabolism.
P2860
Q26740198-EAFD73C9-FD43-4E2B-B110-DD14EE0F92A2Q26767339-E6AA00E3-8974-4B7F-B802-792F05B3580AQ26779128-95B29158-DCBF-41A7-87BE-2B66931AF3B2Q26801181-9357E2D4-5FB8-4247-9F30-78FE46696DB7Q26801487-BAD11F35-4703-4E88-9834-3FBD141E24CCQ26859021-55756E30-E7F7-4662-A7F0-ECC58A067356Q27023295-0CB632EC-8E6F-414F-8761-6E1DC093A9A9Q27026846-FEC2776D-BB56-4095-9823-01CB5B90FC2FQ28087258-45D4C13A-A33B-41F4-92DE-04D655E5CE9AQ28391426-151F3C56-B4C1-42D0-90ED-C8334FC2BE22Q28540355-DD4BAE1A-9C66-4A91-9201-9483B716C0CDQ28551988-6D8AE1B3-160A-4F6A-9931-B2363C6DD347Q33632091-94A305A2-E9DB-4877-8146-552840615BBCQ33915812-0DC6ADE3-473B-4A5C-A869-EF724DB13CEAQ35093800-DB8F370C-D2D1-4938-8B24-3C635D588757Q35097923-A7E771F2-4F4D-4ED0-8E5E-577EAAA30CE2Q35346350-23C98E2A-FFC4-4CB8-8FAA-B6F11A80F2F1Q35476690-ECF7E6A9-05AE-4B24-91AC-12096D33FF88Q35591371-B51439FF-41ED-4103-A3BE-8AC0F96E1DABQ35619546-EAE51F40-A171-4DEC-A9A7-7700A18BE6EFQ35738706-068D81D9-18AD-4BF4-886B-FF425021EE09Q35822837-700C8529-0868-4685-A644-B49C9F8E25DFQ36029524-788E9E26-761A-41E4-8892-A0B4C584F954Q36299692-ABDE9AA8-E0C5-42D9-9005-39A5F66F9431Q36482989-EB65F901-DB2D-438D-8D2C-5F8892745F68Q37723415-E18D4925-78D1-4ADA-B3B8-0719FE7071DFQ38210478-C4CEBE50-CB81-4398-953C-B10724AAC5F2Q38221090-5D246009-4A92-493F-BE3E-9925289F1740Q38259337-C84B1D93-A7B8-4FAB-8131-A4014AE13EE8Q38282842-63E5D17E-9542-4631-8028-52788A140FBDQ38287647-80F0F247-E372-495C-A677-47B7DA6DB8C6Q38296021-DA8A9D90-73A5-49D1-BB18-D9E3B9FA4A7BQ38351487-3BE9212D-4446-41D7-AC7A-DBB5EAAFE851Q38537772-7E5E2CAD-3726-4425-8F8C-5778A5C7B699Q38669417-AADE8752-96EC-4154-9B37-96E1EFC517EBQ38680909-AC4B3056-021A-4940-810A-CF67DE1830F8Q38682574-362762D8-D504-4E5F-8F2E-5FAD186709D2Q38715316-AA876302-66C6-44AA-BD55-335CF80884C6Q38764098-7CD256D2-3A8D-4AD5-832F-532B119A17C5Q38786731-E9FEA6C3-817C-4164-8043-6EE95C339340
P2860
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@ast
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@en
Miravirsen
@nl
type
label
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@ast
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@en
Miravirsen
@nl
prefLabel
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@ast
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@en
Miravirsen
@nl
P2093
P2860
P356
P1476
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
@en
P2093
Jonathan Hall
Mario A E Rebhan
Markus Stoffel
Rémy Denzler
Silvia E M Crivelli
P2860
P304
P356
10.1093/NAR/GKT852
P407
P577
2013-09-24T00:00:00Z